AASS-IN-1 (Compound S-105), an inhibitor of 2-aminoadipic semialdehyde synthase (AASS), demonstrates an IC50 of 142 µM. It acts by targeting the LOR domain of AASS, inhibiting its activity. This compound is notably relevant for hyperlysinemia research.
Molecular Weight:
309.79
Formula:
C15H20ClN3O2
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
